MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 64 filers reported holding MIRATI THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $15,401,000 | +34.0% | 210,115 | -22.4% | 0.01% | +22.2% |
Q4 2018 | $11,492,000 | +118.5% | 270,906 | +142.6% | 0.01% | +350.0% |
Q3 2018 | $5,260,000 | +89.1% | 111,658 | +97.9% | 0.00% | 0.0% |
Q2 2018 | $2,782,000 | +945.9% | 56,434 | +10.2% | 0.00% | – |
Q1 2017 | $266,000 | -6.7% | 51,202 | -14.7% | 0.00% | – |
Q4 2016 | $285,000 | -45.5% | 60,041 | -24.1% | 0.00% | – |
Q3 2016 | $523,000 | +90.2% | 79,147 | +57.1% | 0.00% | – |
Q2 2016 | $275,000 | -63.7% | 50,372 | +42.3% | 0.00% | -100.0% |
Q1 2016 | $757,000 | -32.3% | 35,395 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,118,000 | -0.8% | 35,395 | +8.1% | 0.00% | 0.0% |
Q3 2015 | $1,127,000 | +6.5% | 32,729 | -2.7% | 0.00% | 0.0% |
Q2 2015 | $1,058,000 | +32.1% | 33,632 | +23.2% | 0.00% | 0.0% |
Q1 2015 | $801,000 | +58.3% | 27,309 | 0.0% | 0.00% | – |
Q4 2014 | $506,000 | +4.5% | 27,309 | -1.2% | 0.00% | – |
Q3 2014 | $484,000 | -12.5% | 27,630 | 0.0% | 0.00% | – |
Q2 2014 | $553,000 | – | 27,630 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $257,839,000 | 68.01% |
Boxer Capital, LLC | 2,000,000 | $164,440,000 | 8.45% |
Avoro Capital Advisors LLC | 5,325,000 | $437,822,000 | 7.99% |
M28 Capital Management LP | 82,900 | $6,816,000 | 6.27% |
Artal Group S.A. | 1,350,000 | $110,997,000 | 4.65% |
Nextech Invest Ltd. | 173,300 | $14,249,000 | 4.07% |
Perceptive Advisors | 2,380,710 | $195,742,000 | 3.92% |
Logos Global Management LP | 350,000 | $28,777,000 | 3.73% |
Camber Capital Management LP | 1,200,000 | $98,664,000 | 3.57% |
RTW INVESTMENTS, LP | 1,561,497 | $128,386,000 | 2.66% |